Quantcast
Last updated on April 23, 2014 at 21:24 EDT

US Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers

October 2, 2013

Reportbuyer.com just published a new market research report: US Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers.

London (PRWEB) October 02, 2013

This report presents a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:

•Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.

•Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.

•Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.

•Five- and ten-year reagent and instrument sales forecasts.

•Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.

•Sales and market shares of leading reagent and instrument suppliers.

•Review of current and emerging technologies and their potential market applications.

•Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.

•Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

•Market penetration strategies, entry barriers and risks.

Contains 600 pages and 120 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests

1. Albumin

2. Alkaline Phosphatase

3. ALT/SGPT

4. Ammonia

5. Amylase

6. AST/SGOT

7. Bilirubin, Total

8. Blood Gases

9. Blood Urea Nitrogen (BUN)

10. Calcium

11. Cardio CRP

12. Cholesterol

13. Cholinesterase

14. CRP

15. Creatinine

16. Electrolytes

a. Carbon Dioxide/Bicarbonate

b. Chloride

c. Potassium

d. Sodium

17. Ferritin

18. Fructosamine

19. Gamma-Glutamyl Transpeptidase (GGT)

20. Glucose

21. High Density Lipoprotein (HDL)

22. Homocysteine

23. Iron

24. Lactate Dehydrogenase (LDH)

25. Magnesium

26. Phosphorus

27. Protein

28. Triglycerides

29. Uric Acid

30. Troponin

B. Therapeutic Drug Monitoring (TDM)

1. Overview

2. Carbamazepine

3. Cyclosporin

4. Digoxin

5. Everolimus

6. Gentamicin

7. Lamotrigine/Lamictal

8. Levetiracetam

9. Lidocaine

10. Lithium

11. NAPA/Procainamide

12. Phenytoin

13. Quinidine

14. Sirolimus

15. Tacrolimus

16. Theophylline

17. Topirimate

18. Valproic Acid

C. Endocrine Function Tests

1. Cortisol

2. Follicle-Stimulating Hormone (FSH)

3. Gastrin

4. Growth Hormone/IGF-1

5. Human Chorionic Gonadotropin (HCG)

6. LH

7. PTH/IO PTH

8. Prolactin

9. T3

10. T3 Free

11. T3 Uptake

12. T4 (Thyroxine)

13. T4 Free

14. TBG

15. Thyroglobulin Ab

16. TPO Ab

17. TSH

D. Tumor Markers And Special Chemistry Tests

1. AFP

2. CA 15-3

3. CA 19-9

4. CA 27-29

5. Carcinoembrionic Antigen (CEA)

6. Folate/Folic Acid

7. HCG

8. 25-Hydroxy Vitamin D2 and D3

9. Occult Blood

10. Prostate-Specific Antigen (PSA)

11. Thyroglobulin

12. Vitamin B-12

E. Immunoprotein Tests

1. Complement

a. C3

b. C4

2. Free Light Chains

3. Immunofixation

4. Immunoglobulins (IgA, IgE, IgG, IgM)

5. Haptoglobin

6. Prealbumin

7. Protein Electrophoresis

F. Drugs of Abuse

1. Overview

2. Test Methodologies

3. Amphetamines

4. Barbiturates

5. Benzodiazepines

6. Cannabinoids/Marijuana

7. Cocaine

8. Lysergic Acid Diethylamide (LSD)

9. Methadone

10. Methaqualone

11. Opiates

12. Phencyclidine

13. Tricyclic Antidepressants

G. Instrumentation Review: Operating Characteristics

and Features of High-, Medium-, and Low- Volume/POC

Analyzers Manufactured By:

°Abaxis

°Abbott

°Alere/Inverness

°Alfa Wassermann

°AMS

°Awareness Technologies

°Beckman Coulter/Olympus

°Binding Site

°bioMerieux

°Carolina Chemistries

°DiaSorin

°Grifols

°Horiba

°Medica

°Nova Biomedical

°Ortho-Clinical Diagnostics

°Polymedco

°Randox

°Roche

°Siemens

°Tosoh

°Vital Diagnostics

H. Major In Vitro Diagnostic Technologies

And Their Potential Applications

1. Monoclonal and Polyclonal Antibodies

2. Immunoassays

a. Technological Principle

d. Chemiluminescence

c. Enzyme Immunoassays (EIA)

°Overview

°ELISA

°EMIT

°Electrochemical

d. Radioimmunoassays (RIA)

e. Immunoprecipitation

f. Affinity Chromatography

3. Tandem Mass Spec

4. IT and Automation

5. Dry Chemistry

6. Biosensors

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Industry Consolidation

4. Managed Care

5. Hospitals

6. Admissions

7. Length of Stay

8. Industry Diversification

9. Physician Demographics

10. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

11. Laboratory Regulations

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial/Private Laboratories

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point-of-Care Testing

c. Home/Self Testing

d. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers'

Instrument and Reagent Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

-Abbott Laboratories

-AdnaGen

-Beckman Coulter/Danaher

-Biomedical Diagnostics

-BioMerieux

-Bio-Rad

-Dako

-DiaSorin

-Eiken

-Fujirebio

-Instrumentation Laboratory

-Kyowa Medex

-Matritech

-Ortho-Clinical Diagnostics

-Roche

-Siemens

-Sysmex

-Thermo Fisher

-Tosoh

-Wako

-Wallac/PE

List of Tables

Major Companies Developing or Marketing

Albumin Tests

Major Companies Developing or Marketing

Alkaline Phosphatase Tests

Major Companies Developing or Marketing

ALT/SGPT Tests

Major Companies Developing or Marketing

Amylase Tests

Major Companies Developing or Marketing

AST/SGOT Tests

Major Companies Developing or Marketing

Bilirubin Tests

Major Companies Developing or Marketing

Blood Gas Analyzers

Major Companies Developing or Marketing

BUN Tests

Major Companies Developing or Marketing

Calcium Tests

Major Companies Developing or Marketing

Cholesterol Tests

Major Companies Developing or Marketing

Creatinine Tests

Major Companies Developing or Marketing

Electrolyte Tests

Major Companies Developing or Marketing

GGT Tests

Major Companies Developing or Marketing

Glucose Tests

Major Companies Developing or Marketing

HDL Tests

Major Companies Developing or Marketing

Iron Tests

Major Companies Developing or Marketing

LDH Tests

Major Companies Developing or Marketing

Magnesium Tests

Major Companies Developing or Marketing

Phosphorus Tests

Major Companies Developing or Marketing

Protein Tests

Major Companies Developing or Marketing

Triglycerides Tests

Major Companies Developing or Marketing

Uric Acid Tests

Major Companies Developing or Marketing

TDM Tests

Major Companies Developing or Marketing

Digoxin Tests

Major Companies Developing or Marketing

Lithium Tests

Major Companies Developing or Marketing

Phenytoin/Dilantin Tests

Major Companies Developing or Marketing

Theophylline Tests

Major Companies Developing or Marketing

Valproic Acid Tests

Major Companies Developing or Marketing

FSH Tests

Major Companies Developing or Marketing

HCG Tests

Major Companies Developing or Marketing

LH Tests

Major Companies Developing or Marketing

Prolactin Tests

Major Companies Developing or Marketing

T3 Tests

Major Companies Developing or Marketing

T4 Tests

Major Companies Developing or Marketing

TSH Tests

Major Companies Developing or Marketing

AFP Tests

Major Companies Developing or Marketing

CEA Tests

Major Companies Developing or Marketing

Ferritin Tests

Major Companies Developing or Marketing

Occult Blood Tests

Major Companies Developing or Marketing

Prostatic Acid Phosphatase Tests

Major Companies Developing or Marketing

PSA Tests

Major Companies Developing or Marketing

Vitamin B-12/Folate Tests

Major Companies Developing or Marketing

CRP Tests

Major Companies Developing or Marketing

Drugs of Abuse Tests

Major Companies Developing or Marketing

Biosensors for Immunological Testing

Executive Summary Table: U.S.A., Clinical

Chemistry and Immunoassay Test Volume

and Diagnostics Sales Forecast By Test Category

U.S.A., Laboratories Performing Chemistry

and Immunoassay Testing By Market Segment

U.S.A., Hospital Laboratories Performing

Chemistry and Immunoassay Tests By Bed Size

U.S.A., Commercial/Private Laboratories

Performing Chemistry and Immunoassay Tests

By Annual Test Volume

U.S.A., Total Chemistry and Immunoassay

Specimen Volume Forecast

U.S.A., All Market Segments, Specimen Volume

Forecast By Test Category

U.S.A., Total Clinical Chemistry and Immunoassay

Test Volume Forecast By Test Category

U.S.A., Routine Chemistry Test Volume

Forecast By Market Segment

U.S.A., TDM Test Volume Forecast

By Market Segment

U.S.A., Endocrine Function Test Volume

Forecast By Market Segment

U.S.A., Drugs of Abuse Test Volume

Forecast By Market Segment

U.S.A., Tumor Markers and Special Chemistry

Test Volume Forecast By Market Segment

U.S.A., Immunoprotein Test Volume

Forecast By Market Segment

U.S.A., All Market Segments, Profiles,

Panels and Individual Tests Forecast

U.S.A., Hospital Laboratories, Profiles,

Panels and Individual Tests Forecast

U.S.A., Commercial/Private Laboratories,

Profiles, Panels and Individual Tests Forecast

U.S.A., Physician Offices/Group Practices,

Profiles, Panels and Individual Tests Forecast

U.S.A., All Market Segments, Routine

Chemistry Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories, Routine

Chemistry Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Routine Chemistry Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Routine Chemistry Test Volume Forecast

by Assay

U.S.A., All Market Segments, TDM

Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, TDM

Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

TDM Test Volume Forecast by Assay

U.S.A., Physician Offices/Group Practices,

TDM Test Volume Forecast by Assay

U.S.A., All Market Segments, Endocrine

Function Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, Endocrine

Function Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Endocrine Function Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Endocrine Function Test Volume Forecast

by Assay

U.S.A., All Market Segments, Drugs

of Abuse Test Volume Forecast by Assay

U.S.A., Hospital Laboratories, Drugs

of Abuse Test Volume Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Drugs of Abuse Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Drugs of Abuse Test Volume Forecast

by Assay

U.S.A., All Market Segments, Tumor Markers

and Special Chemistry Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories, Tumor Markers

and Special Chemistry Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Tumor Markers and Special Chemistry Test

Volume Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Tumor Markers and Special Chemistry Test

Volume Forecast by Assay

U.S.A., All Market Segments,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Hospital Laboratories,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Immunoprotein Test Volume Forecast

by Assay

U.S.A., Total Clinical Chemistry and Immunoassay

Reagent Market Forecast By Test Category

U.S.A., Clinical Chemistry and Immunoassay

Calibrator and Control Market Forecast

By Test Category

U.S.A., Routine Chemistry Reagent Market

Forecast By Market Segment

U.S.A., TDM Reagent Market Forecast

By Market Segment

U.S.A., Drugs of Abuse Reagent Market

Forecast By Market Segment

U.S.A., Tumor Markers and Special Chemistry

Reagent Market Forecast By Market Segment

U.S.A., Endocrine Function Reagent Market

Forecast By Market Segment

U.S.A., All Market Segments, Routine

Chemistry Reagent Market Forecast

by Assay

U.S.A., Hospital Laboratories, Routine

Chemistry Reagent Market Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Routine Chemistry Reagent Market Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Routine Chemistry Reagent Market Forecast

by Assay

U.S.A., All Market Segments, TDM

Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, TDM

Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

TDM Reagent Market Forecast by Assay

U.S.A., Physician Office/Group Practices,

TDM Reagent Market Forecast by Assay

U.S.A., All Market Segments, Drugs of

Abuse Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, Drugs of

Abuse Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Drugs of Abuse Reagent Market Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Drugs of Abuse Reagent Market Forecast

by Assay

U.S.A., All Market Segments, Endocrine

Function Reagent Market Forecast by Assay

U.S.A., Hospital Laboratories, Endocrine

Function Reagent Market Forecast by Assay

U.S.A., Commercial/Private Laboratories,

Endocrine Function Reagent Market Forecast

by Assay

U.S.A., Physician Offices/Group Practices,

Endocrine Function Reagent Market Forecast

by Assay

U.S.A., All Market Segments, Tumor Markers

and Special Chemistry Reagent Market Forecast

by Assay

U.S.A., Hospital Laboratories, Tumor Markers

and Special Chemistry Reagent Market Forecast

by Assay

U.S.A., Commercial/Private Laboratories,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., Physician Offices/Group Practices,

Tumor Markers and Special Chemistry Reagent

Market Forecast by Assay

U.S.A., All Market Segments,

Immunoprotein Reagent Market Forecast

U.S.A., Hospital Laboratories,Immunoprotein

Reagent Market Forecast Immunoprotein

U.S.A., Commercial/Private Laboratories,

Immunoprotein Reagent Market Forecast

U.S.A., Physician Offices/Group Practices,

Immunoprotein Reagent Market Forecast

by Assay

U.S.A., Major Suppliers of Clinical Chemistry

Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Clinical Chemistry

Analyzers, Estimated Instrument Sales

and Market Shares

U.S.A., Major Suppliers of Clinical Chemistry

Diagnostics Products, Estimated Sales

and Market Shares

U.S.A., Major Suppliers of Immunoassay

Reagents, Estimated Sales and Market Shares

U.S.A., Major Suppliers of Immunoassay

Analyzers, Estimated Instrument Sales

and Market Shares

U.S.A., Major Suppliers of Immunoassay

Diagnostics Products, Estimated Sales

And Market Shares

Read the full report:

US Clinical Chemistry and Immunodiagnostic Market Outlook: Innovations, Trends and Opportunities for Suppliers

http://www.reportbuyer.com/pharma_healthcare/diagnostics/us_clinical_chemistry_immunodiagnostic_market_outlook_innovations_trends_opportunities_suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11188137.htm


Source: prweb